David Kauffmann

Biography

 Mr. Kauffmann is founding managing partner of European Equity Partners, the chairman of CMC Biologics and ARTS Biologics. Until the merger with SGS in 2006, he also held the position of Chairman of the Management Board of Aster Cephac. Prior to EEP, from 1990, David Kauffmann was a partner of CAI, a North American US$150 million private equity investment fund. Prior to working in private equity and venturecapital, David Kauffmann worked for the American Express Bank in London, New York and Copenhagen, in acquisitions and trade finance. 

Research Interest

 Oncological Research